Research Funded by Box Rallies

Featured Research

Professor Tangye and his team are studying patients with immune deficiencies to understand how errors in specific genes cripple the ability of their immune system to control viral infection and the development of lymphoma.

Explore Research

Advanced pre-clinical evaluation of sphingosine kinase 1-targeting agents as a therapy for acute myeloid leukaemia

Advancing CAR-T cell therapy for extracranial solid paediatric cancers

NSW

Advancing Liquid Biopsy Testing: Harnessing Epigenetics for Early Detection of Residual and Recurrent Breast Cancer

NSW

A patient-derived discovery platform for companion biomarker development in prostate cancer

A targeted therapy to enhance treatment efficacy and neuroprotection in glioblastoma

NSW

CAPP3: a randomized dose finding non inferiority study of aspirin to prevent cancer in Lynch Syndrome

VIC

Creating the Next Generation in Radiotherapy Imaging with Carbon Nanotube Sources and Photon Counting Detectors

NSW

Defining the cellular determinants that drive dynamin inhibitor induced cell death and in vivo efficacy against glioblastoma

NSW

Defining the circulating genome of high-risk plasma cell disorders to improve risk stratification and clinical management

VIC

Defining the critical role of osteoclasts in multiple myeloma cell growth and activation in bone

NSW

Developing a clinic-ready nanomedicine for RNA therapy for pancreatic and lung cancers

NSW

Developing a new blood-based screening test for bowel cancer

NSW

Developing a new strategy to reduce the side effects of bladder cancer treatment

Developing a novel targeted therapy for treating chemotherapy-resistant leukaemia

NSW